title: Interferon-beta plus ribavirin for patients with hepatitis C virus genotype 1: a randomised pilot trial.
authors.forename: M
authors.initials: M
authors.lastname: Enomoto
authors.forename: A
authors.initials: A
authors.lastname: Tamori
authors.forename: N
authors.initials: N
authors.lastname: Kawada
authors.forename: H
authors.initials: H
authors.lastname: Jomura
authors.forename: S
authors.initials: S
authors.lastname: Nishiguchi
authors.forename: T
authors.initials: T
authors.lastname: Saibara
authors.forename: S
authors.initials: S
authors.lastname: Onishi
authors.forename: S
authors.initials: S
authors.lastname: Mochida
authors.forename: K
authors.initials: K
authors.lastname: Fujiwara
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D016899:Interferon-beta / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin; D016899:Interferon-beta